Determining the benefit of levodopa/carbidopa/entacapone (Stalevo®) on the pharmacokinetic profile of levodopa:: a randomized, crossover, multicentre study in patients with Parkinson's disease

被引：0
|
作者：
Marttila, R. [1 ]
Kaasinen, V. [1 ]
Hartikainen, P. [2 ]
Lyytinen, J. [3 ]
Kaakkola, S. [3 ]
Hanninen, J. [4 ,5 ]
Korpela, K. [4 ,5 ]
Laapas, K. [4 ,5 ]
Kuoppamaki, M. [1 ,4 ,5 ]
Ellmen, J. [4 ,5 ]
机构：
[1] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland
[2] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland
[3] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland
[4] Orion Phama, Turku, Finland
[5] Orion Pharma, Espoo, Finland
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2008年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [21] Conversion from sustained release carbidopa/levodopa to Stalevo® in Parkinson's disease patients
    Pahwa, R
    Lyons, KE
    MOVEMENT DISORDERS, 2005, 20 : S71 - S71
  • [22] New levodopa/carbidopa/entacapone (Stalevo®) results in better quality of life for Parkinson's disease patients and saves costs to the society
    Findley, L
    Turunen, H
    Apajasalo, M
    Lees, A
    VALUE IN HEALTH, 2004, 7 (06) : 788 - 788
  • [23] Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
    Hauser, Robert A.
    Panisset, Michel
    Abbruzzese, Giovanni
    Mancione, Linda
    Dronamraju, Nalina
    Kakarieka, Algirdas
    MOVEMENT DISORDERS, 2009, 24 (04) : 541 - 550
  • [24] Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson's Disease Patients
    Mueller, Thomas
    Schlegel, Eugen
    Zingler, Stephanie
    Thiede, Hans Michael
    CELLS, 2022, 11 (09)
  • [25] Levodopa/carbidopa versus levodopa/carbidopa/entacapone as a predictive factor for the development of motor complications in Parkinson's disease
    Olanow, C. W.
    Kieburtz, K.
    Rascol, O.
    Poewe, W.
    Schapira, A.
    Nissinen, H.
    Leinonen, M.
    Stocchi, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 658 - 658
  • [26] Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson’s patients
    F. Stocchi
    L. Barbato
    G. Nordera
    A. Bolner
    T. Caraceni
    Journal of Neural Transmission, 2004, 111 : 173 - 180
  • [27] Optimization of use of levodopa in Parkinson's disease:: role of levodopa-carbidopa-entacapone combination
    Castro, A
    Valldeoriola, F
    Linazasoro, G
    Rodriguez-Oroz, MC
    Stochi, F
    Marín, C
    Rodríguez, M
    Vaamonde, J
    Jenner, P
    Alvarez, L
    Pavón, N
    Macías, R
    Luquín, MR
    Hernández, B
    Grandas, F
    Giménez-Roldán, S
    Tolosa, ES
    Obeso, EJ
    NEUROLOGIA, 2005, 20 (04): : 180 - 188
  • [28] Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson's patients
    Stocchi, F
    Barbato, L
    Nordera, G
    Bolner, A
    Caraceni, T
    JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (02) : 173 - 180
  • [29] Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease
    Mueller, T.
    Erdmann, C.
    Muhlack, S.
    Bremen, D.
    Przuntek, H.
    Goetze, O.
    Woitalla, D.
    JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (10) : 1441 - 1448
  • [30] Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson’s disease
    T. Müller
    C. Erdmann
    S. Muhlack
    D. Bremen
    H. Przuntek
    O. Goetze
    D. Woitalla
    Journal of Neural Transmission, 2006, 113 : 1441 - 1448
12345